Covid-19 Impact on Global Hemoglobinopathies Market Size, Status and Forecast 2020-2026
Hemoglobinopathy or Hemoglobinopathies is the medical term for a group of blood disorders and diseases that affect red blood cells. It can be a kind of genetic defect that results in abnormal structure of one of the globin chains of the hemoglobin molecule.
Increasing cases of hemoglobinopathies, especially in regions such as Southeast Asia and Africa, is one of the major growth drivers.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Hemoglobinopathies market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Hemoglobinopathies industry.
Based on our recent survey, we have several different scenarios about the Hemoglobinopathies YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 270 million in 2019. The market size of Hemoglobinopathies will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hemoglobinopathies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hemoglobinopathies market in terms of revenue.
Players, stakeholders, and other participants in the global Hemoglobinopathies market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Hemoglobinopathies market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Hemoglobinopathies market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hemoglobinopathies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hemoglobinopathies market.
The following players are covered in this report:
Increasing cases of hemoglobinopathies, especially in regions such as Southeast Asia and Africa, is one of the major growth drivers.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Hemoglobinopathies market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Hemoglobinopathies industry.
Based on our recent survey, we have several different scenarios about the Hemoglobinopathies YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 270 million in 2019. The market size of Hemoglobinopathies will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hemoglobinopathies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hemoglobinopathies market in terms of revenue.
Players, stakeholders, and other participants in the global Hemoglobinopathies market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Hemoglobinopathies market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Hemoglobinopathies market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hemoglobinopathies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hemoglobinopathies market.
The following players are covered in this report:
- Gamida Cell
- Alnylam Pharmaceuticals
- Sanofi
- Sangamo Therapeutics Inc.
- Global Blood Therapeutics
- Bluebird Bio
- Emmaus Life Sciences Inc.
- Prolong Pharmaceuticals
- Celgene Corporation
- Blood Transfusion
- Iron Chelation Therapy
- Bone Marrow Transplant
- Others
- Blood Testing
- Genetic Testing
- Pre-Implantation Genetic Diagnosis (PGD)
- Others
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hemoglobinopathies Revenue
1.4 Market Analysis by Type
1.4.1 Global Hemoglobinopathies Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Blood Transfusion
1.4.3 Iron Chelation Therapy
1.4.4 Bone Marrow Transplant
1.4.5 Others
1.5 Market by Application
1.5.1 Global Hemoglobinopathies Market Share by Application: 2020 VS 2026
1.5.2 Blood Testing
1.5.3 Genetic Testing
1.5.4 Pre-Implantation Genetic Diagnosis (PGD)
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Hemoglobinopathies Industry Impact
1.6.1 How the Covid-19 is Affecting the Hemoglobinopathies Industry
1.6.1.1 Hemoglobinopathies Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Hemoglobinopathies Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Hemoglobinopathies Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Hemoglobinopathies Market Perspective (2015-2026)
2.2 Hemoglobinopathies Growth Trends by Regions
2.2.1 Hemoglobinopathies Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hemoglobinopathies Historic Market Share by Regions (2015-2020)
2.2.3 Hemoglobinopathies Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hemoglobinopathies Market Growth Strategy
2.3.6 Primary Interviews with Key Hemoglobinopathies Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Hemoglobinopathies Players by Market Size
3.1.1 Global Top Hemoglobinopathies Players by Revenue (2015-2020)
3.1.2 Global Hemoglobinopathies Revenue Market Share by Players (2015-2020)
3.1.3 Global Hemoglobinopathies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hemoglobinopathies Market Concentration Ratio
3.2.1 Global Hemoglobinopathies Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hemoglobinopathies Revenue in 2019
3.3 Hemoglobinopathies Key Players Head office and Area Served
3.4 Key Players Hemoglobinopathies Product Solution and Service
3.5 Date of Enter into Hemoglobinopathies Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Hemoglobinopathies Historic Market Size by Type (2015-2020)
4.2 Global Hemoglobinopathies Forecasted Market Size by Type (2021-2026)
5 HEMOGLOBINOPATHIES BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Hemoglobinopathies Market Size by Application (2015-2020)
5.2 Global Hemoglobinopathies Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Hemoglobinopathies Market Size (2015-2020)
6.2 Hemoglobinopathies Key Players in North America (2019-2020)
6.3 North America Hemoglobinopathies Market Size by Type (2015-2020)
6.4 North America Hemoglobinopathies Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Hemoglobinopathies Market Size (2015-2020)
7.2 Hemoglobinopathies Key Players in Europe (2019-2020)
7.3 Europe Hemoglobinopathies Market Size by Type (2015-2020)
7.4 Europe Hemoglobinopathies Market Size by Application (2015-2020)
8 CHINA
8.1 China Hemoglobinopathies Market Size (2015-2020)
8.2 Hemoglobinopathies Key Players in China (2019-2020)
8.3 China Hemoglobinopathies Market Size by Type (2015-2020)
8.4 China Hemoglobinopathies Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Hemoglobinopathies Market Size (2015-2020)
9.2 Hemoglobinopathies Key Players in Japan (2019-2020)
9.3 Japan Hemoglobinopathies Market Size by Type (2015-2020)
9.4 Japan Hemoglobinopathies Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Hemoglobinopathies Market Size (2015-2020)
10.2 Hemoglobinopathies Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hemoglobinopathies Market Size by Type (2015-2020)
10.4 Southeast Asia Hemoglobinopathies Market Size by Application (2015-2020)
11 INDIA
11.1 India Hemoglobinopathies Market Size (2015-2020)
11.2 Hemoglobinopathies Key Players in India (2019-2020)
11.3 India Hemoglobinopathies Market Size by Type (2015-2020)
11.4 India Hemoglobinopathies Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Hemoglobinopathies Market Size (2015-2020)
12.2 Hemoglobinopathies Key Players in Central & South America (2019-2020)
12.3 Central & South America Hemoglobinopathies Market Size by Type (2015-2020)
12.4 Central & South America Hemoglobinopathies Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Gamida Cell
13.1.1 Gamida Cell Company Details
13.1.2 Gamida Cell Business Overview and Its Total Revenue
13.1.3 Gamida Cell Hemoglobinopathies Introduction
13.1.4 Gamida Cell Revenue in Hemoglobinopathies Business (2015-2020))
13.1.5 Gamida Cell Recent Development
13.2 Alnylam Pharmaceuticals
13.2.1 Alnylam Pharmaceuticals Company Details
13.2.2 Alnylam Pharmaceuticals Business Overview and Its Total Revenue
13.2.3 Alnylam Pharmaceuticals Hemoglobinopathies Introduction
13.2.4 Alnylam Pharmaceuticals Revenue in Hemoglobinopathies Business (2015-2020)
13.2.5 Alnylam Pharmaceuticals Recent Development
13.3 Sanofi
13.3.1 Sanofi Company Details
13.3.2 Sanofi Business Overview and Its Total Revenue
13.3.3 Sanofi Hemoglobinopathies Introduction
13.3.4 Sanofi Revenue in Hemoglobinopathies Business (2015-2020)
13.3.5 Sanofi Recent Development
13.4 Sangamo Therapeutics Inc.
13.4.1 Sangamo Therapeutics Inc. Company Details
13.4.2 Sangamo Therapeutics Inc. Business Overview and Its Total Revenue
13.4.3 Sangamo Therapeutics Inc. Hemoglobinopathies Introduction
13.4.4 Sangamo Therapeutics Inc. Revenue in Hemoglobinopathies Business (2015-2020)
13.4.5 Sangamo Therapeutics Inc. Recent Development
13.5 Global Blood Therapeutics
13.5.1 Global Blood Therapeutics Company Details
13.5.2 Global Blood Therapeutics Business Overview and Its Total Revenue
13.5.3 Global Blood Therapeutics Hemoglobinopathies Introduction
13.5.4 Global Blood Therapeutics Revenue in Hemoglobinopathies Business (2015-2020)
13.5.5 Global Blood Therapeutics Recent Development
13.6 Bluebird Bio
13.6.1 Bluebird Bio Company Details
13.6.2 Bluebird Bio Business Overview and Its Total Revenue
13.6.3 Bluebird Bio Hemoglobinopathies Introduction
13.6.4 Bluebird Bio Revenue in Hemoglobinopathies Business (2015-2020)
13.6.5 Bluebird Bio Recent Development
13.7 Emmaus Life Sciences Inc.
13.7.1 Emmaus Life Sciences Inc. Company Details
13.7.2 Emmaus Life Sciences Inc. Business Overview and Its Total Revenue
13.7.3 Emmaus Life Sciences Inc. Hemoglobinopathies Introduction
13.7.4 Emmaus Life Sciences Inc. Revenue in Hemoglobinopathies Business (2015-2020)
13.7.5 Emmaus Life Sciences Inc. Recent Development
13.8 Prolong Pharmaceuticals
13.8.1 Prolong Pharmaceuticals Company Details
13.8.2 Prolong Pharmaceuticals Business Overview and Its Total Revenue
13.8.3 Prolong Pharmaceuticals Hemoglobinopathies Introduction
13.8.4 Prolong Pharmaceuticals Revenue in Hemoglobinopathies Business (2015-2020)
13.8.5 Prolong Pharmaceuticals Recent Development
13.9 Celgene Corporation
13.9.1 Celgene Corporation Company Details
13.9.2 Celgene Corporation Business Overview and Its Total Revenue
13.9.3 Celgene Corporation Hemoglobinopathies Introduction
13.9.4 Celgene Corporation Revenue in Hemoglobinopathies Business (2015-2020)
13.9.5 Celgene Corporation Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hemoglobinopathies Revenue
1.4 Market Analysis by Type
1.4.1 Global Hemoglobinopathies Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Blood Transfusion
1.4.3 Iron Chelation Therapy
1.4.4 Bone Marrow Transplant
1.4.5 Others
1.5 Market by Application
1.5.1 Global Hemoglobinopathies Market Share by Application: 2020 VS 2026
1.5.2 Blood Testing
1.5.3 Genetic Testing
1.5.4 Pre-Implantation Genetic Diagnosis (PGD)
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Hemoglobinopathies Industry Impact
1.6.1 How the Covid-19 is Affecting the Hemoglobinopathies Industry
1.6.1.1 Hemoglobinopathies Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Hemoglobinopathies Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Hemoglobinopathies Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Hemoglobinopathies Market Perspective (2015-2026)
2.2 Hemoglobinopathies Growth Trends by Regions
2.2.1 Hemoglobinopathies Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hemoglobinopathies Historic Market Share by Regions (2015-2020)
2.2.3 Hemoglobinopathies Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hemoglobinopathies Market Growth Strategy
2.3.6 Primary Interviews with Key Hemoglobinopathies Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Hemoglobinopathies Players by Market Size
3.1.1 Global Top Hemoglobinopathies Players by Revenue (2015-2020)
3.1.2 Global Hemoglobinopathies Revenue Market Share by Players (2015-2020)
3.1.3 Global Hemoglobinopathies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hemoglobinopathies Market Concentration Ratio
3.2.1 Global Hemoglobinopathies Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hemoglobinopathies Revenue in 2019
3.3 Hemoglobinopathies Key Players Head office and Area Served
3.4 Key Players Hemoglobinopathies Product Solution and Service
3.5 Date of Enter into Hemoglobinopathies Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Hemoglobinopathies Historic Market Size by Type (2015-2020)
4.2 Global Hemoglobinopathies Forecasted Market Size by Type (2021-2026)
5 HEMOGLOBINOPATHIES BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Hemoglobinopathies Market Size by Application (2015-2020)
5.2 Global Hemoglobinopathies Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Hemoglobinopathies Market Size (2015-2020)
6.2 Hemoglobinopathies Key Players in North America (2019-2020)
6.3 North America Hemoglobinopathies Market Size by Type (2015-2020)
6.4 North America Hemoglobinopathies Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Hemoglobinopathies Market Size (2015-2020)
7.2 Hemoglobinopathies Key Players in Europe (2019-2020)
7.3 Europe Hemoglobinopathies Market Size by Type (2015-2020)
7.4 Europe Hemoglobinopathies Market Size by Application (2015-2020)
8 CHINA
8.1 China Hemoglobinopathies Market Size (2015-2020)
8.2 Hemoglobinopathies Key Players in China (2019-2020)
8.3 China Hemoglobinopathies Market Size by Type (2015-2020)
8.4 China Hemoglobinopathies Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Hemoglobinopathies Market Size (2015-2020)
9.2 Hemoglobinopathies Key Players in Japan (2019-2020)
9.3 Japan Hemoglobinopathies Market Size by Type (2015-2020)
9.4 Japan Hemoglobinopathies Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Hemoglobinopathies Market Size (2015-2020)
10.2 Hemoglobinopathies Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hemoglobinopathies Market Size by Type (2015-2020)
10.4 Southeast Asia Hemoglobinopathies Market Size by Application (2015-2020)
11 INDIA
11.1 India Hemoglobinopathies Market Size (2015-2020)
11.2 Hemoglobinopathies Key Players in India (2019-2020)
11.3 India Hemoglobinopathies Market Size by Type (2015-2020)
11.4 India Hemoglobinopathies Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Hemoglobinopathies Market Size (2015-2020)
12.2 Hemoglobinopathies Key Players in Central & South America (2019-2020)
12.3 Central & South America Hemoglobinopathies Market Size by Type (2015-2020)
12.4 Central & South America Hemoglobinopathies Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Gamida Cell
13.1.1 Gamida Cell Company Details
13.1.2 Gamida Cell Business Overview and Its Total Revenue
13.1.3 Gamida Cell Hemoglobinopathies Introduction
13.1.4 Gamida Cell Revenue in Hemoglobinopathies Business (2015-2020))
13.1.5 Gamida Cell Recent Development
13.2 Alnylam Pharmaceuticals
13.2.1 Alnylam Pharmaceuticals Company Details
13.2.2 Alnylam Pharmaceuticals Business Overview and Its Total Revenue
13.2.3 Alnylam Pharmaceuticals Hemoglobinopathies Introduction
13.2.4 Alnylam Pharmaceuticals Revenue in Hemoglobinopathies Business (2015-2020)
13.2.5 Alnylam Pharmaceuticals Recent Development
13.3 Sanofi
13.3.1 Sanofi Company Details
13.3.2 Sanofi Business Overview and Its Total Revenue
13.3.3 Sanofi Hemoglobinopathies Introduction
13.3.4 Sanofi Revenue in Hemoglobinopathies Business (2015-2020)
13.3.5 Sanofi Recent Development
13.4 Sangamo Therapeutics Inc.
13.4.1 Sangamo Therapeutics Inc. Company Details
13.4.2 Sangamo Therapeutics Inc. Business Overview and Its Total Revenue
13.4.3 Sangamo Therapeutics Inc. Hemoglobinopathies Introduction
13.4.4 Sangamo Therapeutics Inc. Revenue in Hemoglobinopathies Business (2015-2020)
13.4.5 Sangamo Therapeutics Inc. Recent Development
13.5 Global Blood Therapeutics
13.5.1 Global Blood Therapeutics Company Details
13.5.2 Global Blood Therapeutics Business Overview and Its Total Revenue
13.5.3 Global Blood Therapeutics Hemoglobinopathies Introduction
13.5.4 Global Blood Therapeutics Revenue in Hemoglobinopathies Business (2015-2020)
13.5.5 Global Blood Therapeutics Recent Development
13.6 Bluebird Bio
13.6.1 Bluebird Bio Company Details
13.6.2 Bluebird Bio Business Overview and Its Total Revenue
13.6.3 Bluebird Bio Hemoglobinopathies Introduction
13.6.4 Bluebird Bio Revenue in Hemoglobinopathies Business (2015-2020)
13.6.5 Bluebird Bio Recent Development
13.7 Emmaus Life Sciences Inc.
13.7.1 Emmaus Life Sciences Inc. Company Details
13.7.2 Emmaus Life Sciences Inc. Business Overview and Its Total Revenue
13.7.3 Emmaus Life Sciences Inc. Hemoglobinopathies Introduction
13.7.4 Emmaus Life Sciences Inc. Revenue in Hemoglobinopathies Business (2015-2020)
13.7.5 Emmaus Life Sciences Inc. Recent Development
13.8 Prolong Pharmaceuticals
13.8.1 Prolong Pharmaceuticals Company Details
13.8.2 Prolong Pharmaceuticals Business Overview and Its Total Revenue
13.8.3 Prolong Pharmaceuticals Hemoglobinopathies Introduction
13.8.4 Prolong Pharmaceuticals Revenue in Hemoglobinopathies Business (2015-2020)
13.8.5 Prolong Pharmaceuticals Recent Development
13.9 Celgene Corporation
13.9.1 Celgene Corporation Company Details
13.9.2 Celgene Corporation Business Overview and Its Total Revenue
13.9.3 Celgene Corporation Hemoglobinopathies Introduction
13.9.4 Celgene Corporation Revenue in Hemoglobinopathies Business (2015-2020)
13.9.5 Celgene Corporation Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Hemoglobinopathies Key Market Segments
Table 2. Key Players Covered: Ranking by Hemoglobinopathies Revenue
Table 3. Ranking of Global Top Hemoglobinopathies Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hemoglobinopathies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Blood Transfusion
Table 6. Key Players of Iron Chelation Therapy
Table 7. Key Players of Bone Marrow Transplant
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four Hemoglobinopathies Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Hemoglobinopathies Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Hemoglobinopathies Players to Combat Covid-19 Impact
Table 14. Global Hemoglobinopathies Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Hemoglobinopathies Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Hemoglobinopathies Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Hemoglobinopathies Market Share by Regions (2015-2020)
Table 18. Global Hemoglobinopathies Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Hemoglobinopathies Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Hemoglobinopathies Market Growth Strategy
Table 24. Main Points Interviewed from Key Hemoglobinopathies Players
Table 25. Global Hemoglobinopathies Revenue by Players (2015-2020) (Million US$)
Table 26. Global Hemoglobinopathies Market Share by Players (2015-2020)
Table 27. Global Top Hemoglobinopathies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemoglobinopathies as of 2019)
Table 28. Global Hemoglobinopathies by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Hemoglobinopathies Product Solution and Service
Table 31. Date of Enter into Hemoglobinopathies Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Hemoglobinopathies Market Size by Type (2015-2020) (Million US$)
Table 34. Global Hemoglobinopathies Market Size Share by Type (2015-2020)
Table 35. Global Hemoglobinopathies Revenue Market Share by Type (2021-2026)
Table 36. Global Hemoglobinopathies Market Size Share by Application (2015-2020)
Table 37. Global Hemoglobinopathies Market Size by Application (2015-2020) (Million US$)
Table 38. Global Hemoglobinopathies Market Size Share by Application (2021-2026)
Table 39. North America Key Players Hemoglobinopathies Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Hemoglobinopathies Market Share (2019-2020)
Table 41. North America Hemoglobinopathies Market Size by Type (2015-2020) (Million US$)
Table 42. North America Hemoglobinopathies Market Share by Type (2015-2020)
Table 43. North America Hemoglobinopathies Market Size by Application (2015-2020) (Million US$)
Table 44. North America Hemoglobinopathies Market Share by Application (2015-2020)
Table 45. Europe Key Players Hemoglobinopathies Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Hemoglobinopathies Market Share (2019-2020)
Table 47. Europe Hemoglobinopathies Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Hemoglobinopathies Market Share by Type (2015-2020)
Table 49. Europe Hemoglobinopathies Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Hemoglobinopathies Market Share by Application (2015-2020)
Table 51. China Key Players Hemoglobinopathies Revenue (2019-2020) (Million US$)
Table 52. China Key Players Hemoglobinopathies Market Share (2019-2020)
Table 53. China Hemoglobinopathies Market Size by Type (2015-2020) (Million US$)
Table 54. China Hemoglobinopathies Market Share by Type (2015-2020)
Table 55. China Hemoglobinopathies Market Size by Application (2015-2020) (Million US$)
Table 56. China Hemoglobinopathies Market Share by Application (2015-2020)
Table 57. Japan Key Players Hemoglobinopathies Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Hemoglobinopathies Market Share (2019-2020)
Table 59. Japan Hemoglobinopathies Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Hemoglobinopathies Market Share by Type (2015-2020)
Table 61. Japan Hemoglobinopathies Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Hemoglobinopathies Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Hemoglobinopathies Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Hemoglobinopathies Market Share (2019-2020)
Table 65. Southeast Asia Hemoglobinopathies Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Hemoglobinopathies Market Share by Type (2015-2020)
Table 67. Southeast Asia Hemoglobinopathies Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Hemoglobinopathies Market Share by Application (2015-2020)
Table 69. India Key Players Hemoglobinopathies Revenue (2019-2020) (Million US$)
Table 70. India Key Players Hemoglobinopathies Market Share (2019-2020)
Table 71. India Hemoglobinopathies Market Size by Type (2015-2020) (Million US$)
Table 72. India Hemoglobinopathies Market Share by Type (2015-2020)
Table 73. India Hemoglobinopathies Market Size by Application (2015-2020) (Million US$)
Table 74. India Hemoglobinopathies Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Hemoglobinopathies Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Hemoglobinopathies Market Share (2019-2020)
Table 77. Central & South America Hemoglobinopathies Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Hemoglobinopathies Market Share by Type (2015-2020)
Table 79. Central & South America Hemoglobinopathies Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Hemoglobinopathies Market Share by Application (2015-2020)
Table 81. Gamida Cell Company Details
Table 82. Gamida Cell Business Overview
Table 83. Gamida Cell Product
Table 84. Gamida Cell Revenue in Hemoglobinopathies Business (2015-2020) (Million US$)
Table 85. Gamida Cell Recent Development
Table 86. Alnylam Pharmaceuticals Company Details
Table 87. Alnylam Pharmaceuticals Business Overview
Table 88. Alnylam Pharmaceuticals Product
Table 89. Alnylam Pharmaceuticals Revenue in Hemoglobinopathies Business (2015-2020) (Million US$)
Table 90. Alnylam Pharmaceuticals Recent Development
Table 91. Sanofi Company Details
Table 92. Sanofi Business Overview
Table 93. Sanofi Product
Table 94. Sanofi Revenue in Hemoglobinopathies Business (2015-2020) (Million US$)
Table 95. Sanofi Recent Development
Table 96. Sangamo Therapeutics Inc. Company Details
Table 97. Sangamo Therapeutics Inc. Business Overview
Table 98. Sangamo Therapeutics Inc. Product
Table 99. Sangamo Therapeutics Inc. Revenue in Hemoglobinopathies Business (2015-2020) (Million US$)
Table 100. Sangamo Therapeutics Inc. Recent Development
Table 101. Global Blood Therapeutics Company Details
Table 102. Global Blood Therapeutics Business Overview
Table 103. Global Blood Therapeutics Product
Table 104. Global Blood Therapeutics Revenue in Hemoglobinopathies Business (2015-2020) (Million US$)
Table 105. Global Blood Therapeutics Recent Development
Table 106. Bluebird Bio Company Details
Table 107. Bluebird Bio Business Overview
Table 108. Bluebird Bio Product
Table 109. Bluebird Bio Revenue in Hemoglobinopathies Business (2015-2020) (Million US$)
Table 110. Bluebird Bio Recent Development
Table 111. Emmaus Life Sciences Inc. Company Details
Table 112. Emmaus Life Sciences Inc. Business Overview
Table 113. Emmaus Life Sciences Inc. Product
Table 114. Emmaus Life Sciences Inc. Revenue in Hemoglobinopathies Business (2015-2020) (Million US$)
Table 115. Emmaus Life Sciences Inc. Recent Development
Table 116. Prolong Pharmaceuticals Business Overview
Table 117. Prolong Pharmaceuticals Product
Table 118. Prolong Pharmaceuticals Company Details
Table 119. Prolong Pharmaceuticals Revenue in Hemoglobinopathies Business (2015-2020) (Million US$)
Table 120. Prolong Pharmaceuticals Recent Development
Table 121. Celgene Corporation Company Details
Table 122. Celgene Corporation Business Overview
Table 123. Celgene Corporation Product
Table 124. Celgene Corporation Revenue in Hemoglobinopathies Business (2015-2020) (Million US$)
Table 125. Celgene Corporation Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 1. Hemoglobinopathies Key Market Segments
Table 2. Key Players Covered: Ranking by Hemoglobinopathies Revenue
Table 3. Ranking of Global Top Hemoglobinopathies Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hemoglobinopathies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Blood Transfusion
Table 6. Key Players of Iron Chelation Therapy
Table 7. Key Players of Bone Marrow Transplant
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four Hemoglobinopathies Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Hemoglobinopathies Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Hemoglobinopathies Players to Combat Covid-19 Impact
Table 14. Global Hemoglobinopathies Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Hemoglobinopathies Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Hemoglobinopathies Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Hemoglobinopathies Market Share by Regions (2015-2020)
Table 18. Global Hemoglobinopathies Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Hemoglobinopathies Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Hemoglobinopathies Market Growth Strategy
Table 24. Main Points Interviewed from Key Hemoglobinopathies Players
Table 25. Global Hemoglobinopathies Revenue by Players (2015-2020) (Million US$)
Table 26. Global Hemoglobinopathies Market Share by Players (2015-2020)
Table 27. Global Top Hemoglobinopathies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemoglobinopathies as of 2019)
Table 28. Global Hemoglobinopathies by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Hemoglobinopathies Product Solution and Service
Table 31. Date of Enter into Hemoglobinopathies Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Hemoglobinopathies Market Size by Type (2015-2020) (Million US$)
Table 34. Global Hemoglobinopathies Market Size Share by Type (2015-2020)
Table 35. Global Hemoglobinopathies Revenue Market Share by Type (2021-2026)
Table 36. Global Hemoglobinopathies Market Size Share by Application (2015-2020)
Table 37. Global Hemoglobinopathies Market Size by Application (2015-2020) (Million US$)
Table 38. Global Hemoglobinopathies Market Size Share by Application (2021-2026)
Table 39. North America Key Players Hemoglobinopathies Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Hemoglobinopathies Market Share (2019-2020)
Table 41. North America Hemoglobinopathies Market Size by Type (2015-2020) (Million US$)
Table 42. North America Hemoglobinopathies Market Share by Type (2015-2020)
Table 43. North America Hemoglobinopathies Market Size by Application (2015-2020) (Million US$)
Table 44. North America Hemoglobinopathies Market Share by Application (2015-2020)
Table 45. Europe Key Players Hemoglobinopathies Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Hemoglobinopathies Market Share (2019-2020)
Table 47. Europe Hemoglobinopathies Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Hemoglobinopathies Market Share by Type (2015-2020)
Table 49. Europe Hemoglobinopathies Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Hemoglobinopathies Market Share by Application (2015-2020)
Table 51. China Key Players Hemoglobinopathies Revenue (2019-2020) (Million US$)
Table 52. China Key Players Hemoglobinopathies Market Share (2019-2020)
Table 53. China Hemoglobinopathies Market Size by Type (2015-2020) (Million US$)
Table 54. China Hemoglobinopathies Market Share by Type (2015-2020)
Table 55. China Hemoglobinopathies Market Size by Application (2015-2020) (Million US$)
Table 56. China Hemoglobinopathies Market Share by Application (2015-2020)
Table 57. Japan Key Players Hemoglobinopathies Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Hemoglobinopathies Market Share (2019-2020)
Table 59. Japan Hemoglobinopathies Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Hemoglobinopathies Market Share by Type (2015-2020)
Table 61. Japan Hemoglobinopathies Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Hemoglobinopathies Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Hemoglobinopathies Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Hemoglobinopathies Market Share (2019-2020)
Table 65. Southeast Asia Hemoglobinopathies Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Hemoglobinopathies Market Share by Type (2015-2020)
Table 67. Southeast Asia Hemoglobinopathies Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Hemoglobinopathies Market Share by Application (2015-2020)
Table 69. India Key Players Hemoglobinopathies Revenue (2019-2020) (Million US$)
Table 70. India Key Players Hemoglobinopathies Market Share (2019-2020)
Table 71. India Hemoglobinopathies Market Size by Type (2015-2020) (Million US$)
Table 72. India Hemoglobinopathies Market Share by Type (2015-2020)
Table 73. India Hemoglobinopathies Market Size by Application (2015-2020) (Million US$)
Table 74. India Hemoglobinopathies Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Hemoglobinopathies Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Hemoglobinopathies Market Share (2019-2020)
Table 77. Central & South America Hemoglobinopathies Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Hemoglobinopathies Market Share by Type (2015-2020)
Table 79. Central & South America Hemoglobinopathies Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Hemoglobinopathies Market Share by Application (2015-2020)
Table 81. Gamida Cell Company Details
Table 82. Gamida Cell Business Overview
Table 83. Gamida Cell Product
Table 84. Gamida Cell Revenue in Hemoglobinopathies Business (2015-2020) (Million US$)
Table 85. Gamida Cell Recent Development
Table 86. Alnylam Pharmaceuticals Company Details
Table 87. Alnylam Pharmaceuticals Business Overview
Table 88. Alnylam Pharmaceuticals Product
Table 89. Alnylam Pharmaceuticals Revenue in Hemoglobinopathies Business (2015-2020) (Million US$)
Table 90. Alnylam Pharmaceuticals Recent Development
Table 91. Sanofi Company Details
Table 92. Sanofi Business Overview
Table 93. Sanofi Product
Table 94. Sanofi Revenue in Hemoglobinopathies Business (2015-2020) (Million US$)
Table 95. Sanofi Recent Development
Table 96. Sangamo Therapeutics Inc. Company Details
Table 97. Sangamo Therapeutics Inc. Business Overview
Table 98. Sangamo Therapeutics Inc. Product
Table 99. Sangamo Therapeutics Inc. Revenue in Hemoglobinopathies Business (2015-2020) (Million US$)
Table 100. Sangamo Therapeutics Inc. Recent Development
Table 101. Global Blood Therapeutics Company Details
Table 102. Global Blood Therapeutics Business Overview
Table 103. Global Blood Therapeutics Product
Table 104. Global Blood Therapeutics Revenue in Hemoglobinopathies Business (2015-2020) (Million US$)
Table 105. Global Blood Therapeutics Recent Development
Table 106. Bluebird Bio Company Details
Table 107. Bluebird Bio Business Overview
Table 108. Bluebird Bio Product
Table 109. Bluebird Bio Revenue in Hemoglobinopathies Business (2015-2020) (Million US$)
Table 110. Bluebird Bio Recent Development
Table 111. Emmaus Life Sciences Inc. Company Details
Table 112. Emmaus Life Sciences Inc. Business Overview
Table 113. Emmaus Life Sciences Inc. Product
Table 114. Emmaus Life Sciences Inc. Revenue in Hemoglobinopathies Business (2015-2020) (Million US$)
Table 115. Emmaus Life Sciences Inc. Recent Development
Table 116. Prolong Pharmaceuticals Business Overview
Table 117. Prolong Pharmaceuticals Product
Table 118. Prolong Pharmaceuticals Company Details
Table 119. Prolong Pharmaceuticals Revenue in Hemoglobinopathies Business (2015-2020) (Million US$)
Table 120. Prolong Pharmaceuticals Recent Development
Table 121. Celgene Corporation Company Details
Table 122. Celgene Corporation Business Overview
Table 123. Celgene Corporation Product
Table 124. Celgene Corporation Revenue in Hemoglobinopathies Business (2015-2020) (Million US$)
Table 125. Celgene Corporation Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Hemoglobinopathies Market Share by Type: 2020 VS 2026
Figure 2. Blood Transfusion Features
Figure 3. Iron Chelation Therapy Features
Figure 4. Bone Marrow Transplant Features
Figure 5. Others Features
Figure 6. Global Hemoglobinopathies Market Share by Application: 2020 VS 2026
Figure 7. Blood Testing Case Studies
Figure 8. Genetic Testing Case Studies
Figure 9. Pre-Implantation Genetic Diagnosis (PGD) Case Studies
Figure 10. Others Case Studies
Figure 11. Hemoglobinopathies Report Years Considered
Figure 12. Global Hemoglobinopathies Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Hemoglobinopathies Market Share by Regions: 2020 VS 2026
Figure 14. Global Hemoglobinopathies Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Hemoglobinopathies Market Share by Players in 2019
Figure 17. Global Top Hemoglobinopathies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemoglobinopathies as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Hemoglobinopathies Revenue in 2019
Figure 19. North America Hemoglobinopathies Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Hemoglobinopathies Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Hemoglobinopathies Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Hemoglobinopathies Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Hemoglobinopathies Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Hemoglobinopathies Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Hemoglobinopathies Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Gamida Cell Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Gamida Cell Revenue Growth Rate in Hemoglobinopathies Business (2015-2020)
Figure 28. Alnylam Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Alnylam Pharmaceuticals Revenue Growth Rate in Hemoglobinopathies Business (2015-2020)
Figure 30. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Sanofi Revenue Growth Rate in Hemoglobinopathies Business (2015-2020)
Figure 32. Sangamo Therapeutics Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Sangamo Therapeutics Inc. Revenue Growth Rate in Hemoglobinopathies Business (2015-2020)
Figure 34. Global Blood Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Global Blood Therapeutics Revenue Growth Rate in Hemoglobinopathies Business (2015-2020)
Figure 36. Bluebird Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Bluebird Bio Revenue Growth Rate in Hemoglobinopathies Business (2015-2020)
Figure 38. Emmaus Life Sciences Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Emmaus Life Sciences Inc. Revenue Growth Rate in Hemoglobinopathies Business (2015-2020)
Figure 40. Prolong Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Prolong Pharmaceuticals Revenue Growth Rate in Hemoglobinopathies Business (2015-2020)
Figure 42. Celgene Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Celgene Corporation Revenue Growth Rate in Hemoglobinopathies Business (2015-2020)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed
Figure 1. Global Hemoglobinopathies Market Share by Type: 2020 VS 2026
Figure 2. Blood Transfusion Features
Figure 3. Iron Chelation Therapy Features
Figure 4. Bone Marrow Transplant Features
Figure 5. Others Features
Figure 6. Global Hemoglobinopathies Market Share by Application: 2020 VS 2026
Figure 7. Blood Testing Case Studies
Figure 8. Genetic Testing Case Studies
Figure 9. Pre-Implantation Genetic Diagnosis (PGD) Case Studies
Figure 10. Others Case Studies
Figure 11. Hemoglobinopathies Report Years Considered
Figure 12. Global Hemoglobinopathies Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Hemoglobinopathies Market Share by Regions: 2020 VS 2026
Figure 14. Global Hemoglobinopathies Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Hemoglobinopathies Market Share by Players in 2019
Figure 17. Global Top Hemoglobinopathies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemoglobinopathies as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Hemoglobinopathies Revenue in 2019
Figure 19. North America Hemoglobinopathies Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Hemoglobinopathies Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Hemoglobinopathies Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Hemoglobinopathies Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Hemoglobinopathies Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Hemoglobinopathies Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Hemoglobinopathies Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Gamida Cell Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Gamida Cell Revenue Growth Rate in Hemoglobinopathies Business (2015-2020)
Figure 28. Alnylam Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Alnylam Pharmaceuticals Revenue Growth Rate in Hemoglobinopathies Business (2015-2020)
Figure 30. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Sanofi Revenue Growth Rate in Hemoglobinopathies Business (2015-2020)
Figure 32. Sangamo Therapeutics Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Sangamo Therapeutics Inc. Revenue Growth Rate in Hemoglobinopathies Business (2015-2020)
Figure 34. Global Blood Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Global Blood Therapeutics Revenue Growth Rate in Hemoglobinopathies Business (2015-2020)
Figure 36. Bluebird Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Bluebird Bio Revenue Growth Rate in Hemoglobinopathies Business (2015-2020)
Figure 38. Emmaus Life Sciences Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Emmaus Life Sciences Inc. Revenue Growth Rate in Hemoglobinopathies Business (2015-2020)
Figure 40. Prolong Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Prolong Pharmaceuticals Revenue Growth Rate in Hemoglobinopathies Business (2015-2020)
Figure 42. Celgene Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Celgene Corporation Revenue Growth Rate in Hemoglobinopathies Business (2015-2020)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed
